News

FDA to revise labeling of ADHD medication to indicate weight loss risk
The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...
Health and Me on MSN1d
FDA Mandates ADHD Drug Labels To Warn Of Weight Loss Risk
The FDA now requires ADHD extended-release drug labels to warn of weight loss risks in children under 6, urging monitoring ...
Major insurance changes are coming to GLP-1 drugs for weight loss. Here’s how that could affect patients
CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
AARP3d
Medicare Drug Price Negotiations Start Sept. 1
The tens of millions of beneficiaries who get their prescription drugs through Medicare will have an opportunity this fall to let federal officials know the importance and impact of the first 10 ...
AARP3d
AARP’s Yearslong Fight to Lower Prescription Drug Prices
Within the hour, AARP Chief Executive Officer Jo Ann Jenkins issued a statement saying the organization that represents nearly 38 million older Americans was “outraged” that the drug provisions were ...